Leucine Rich Bio, South Asia’s first microbiome company, has announced a strategic partnership with Precision Diagnosticos, a leading diagnostics firm based in Brazil. This collaboration will bring BugSpeaks, Leucine Rich Bio’s flagship microbiome testing technology, to the Brazilian market, enhancing access to cutting-edge microbiome diagnostics and personalized health solutions across both regions.
BugSpeaks is an advanced gut microbiome analysis tool designed to detect microbial imbalances that can contribute to conditions such as obesity, diabetes, and digestive disorders. Through this partnership, Precision Diagnosticos expertise and extensive distribution network will help expand the availability of microbiome testing in Brazil, empowering individuals to take proactive steps toward better health.
Dr Debojyoti Dhar, co-founder and director of Leucine Rich Bio, stated, The Precision Diagnosticos alliance represents a significant step toward democratizing access to advanced microbiome testing in South America. Together, we can empower individuals to take charge of their health through personalized insights derived from their gut microbiota."
In addition to expanding microbiome testing, the partnership will drive educational campaigns to raise awareness about gut health and its crucial role in overall well-being. Healthcare professionals will receive specialized training and resources to integrate microbiome testing into clinical practice, ensuring the technology’s widespread and effective use.
Since its foundation in 2014, Leucine Rich Bio has led advancements in precision medicine and preventive healthcare. As an ISO 9001:2015, ISO 17025:2017, and NABH-accredited company, it continues to push the boundaries of microbiome research.